CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Best Funds Ask the Mole Best Places to Retire Big Tech Blog Techland Blog Sectors and Stocks Fortune 500 Techs Tech Talk 100 Best Places to Launch Ultimate Resource Guide Small Biz Makeovers FSB 100 Ask & Answer Fortune 500 Technology Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts
TRADING
CENTER
Stocks that can ride a pause
With the Fed taking a break, markets may now shift to worrying about an economic slowdown -- bad for profits and stocks. But these sectors may benefit.
By Paul R. La Monica, for Money Magazine

NEW YORK (Money Magazine) -- The Federal Reserve decided Tuesday not to raise interest rates for the first time in more than two years, noting that economic growth had "moderated."

So which sectors are likely to do well now? A recent study from Citigroup looked at the past five runs of Fed rate hikes and examined how stocks performed in the 12 months following each final rate increase.

One-year gain after Fed stops raising rates
  • Financials: + 24.7%
  • Health Care: + 23.4%
  • Consumer Staples: + 17.6%
  • S&P 500: + 9.9%

What they found: Classic defensive plays like pharmaceuticals, financials, utilities and consumer staples (which includes companies such as Coca-Cola and Procter & Gamble) have historically gained twice as much as the S&P 500 once the Fed stops raising rates.

That's because consumers continue buying medicine, drinking soda and paying their electric bill, regardless of the state of the economy.

Within that group, big drug companies look especially attractive, says Sam Stovall, chief investment strategist with Standard & Poor's Equity Research.

Patent expiration fears and high-profile drug-safety scares have depressed drugmakers' stock prices. Meanwhile, the new Medicare prescription drug benefit is expected to hugely increase demand for their products.

"There is the potential for profit growth combined with the interest in the sector's defensive characteristics," Stovall says.

Brad Sorensen, a senior analyst with the Schwab Center for Investment Research, also expects the health-care sector to lead the pack once interest rates stop rising. But he says that if the economy continues to sink, it could be a mixed bag for financial stocks.

Sorensen says big banks like Citigroup (Charts) and J.P. Morgan Chase (Charts) should benefit from greater corporate loan demand and merger activity once rate hikes end.

But investors may want to steer clear of regional banks with major exposure to home loans, since more consumers will likely default on their mortgages if the economy goes sour. "That concerns us," Sorensen says.

______________________

(Correction: An earlier version of this story misquoted Sorensen as saying he was recommending Citigroup and J.P. Morgan Chase specifically. CNNMoney regrets the error).

News: The Fed pauses, but...

Markets: The Street reacts to the Fed decision Top of page

YOUR E-MAIL ALERTS
Follow the news that matters to you. Create your own alert to be notified on topics you're interested in.

Or, visit Popular Alerts for suggestions.
Manage alerts | What is this?
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.